🎉 M&A multiples are live!
Check it out!

Embla Medical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Embla Medical and similar public comparables like SmartVest, Perspective Therapeutics, and Myomo.

Embla Medical Overview

About Embla Medical

Embla Medical hf is is an Iceland-based company that operates within the field of medical equipment and supplies sector. The Company is active in the development and distribution of products in the fields of non-invasive prosthetics, medical braces and supports. Embla Medical operates within three business segments of the non-invasive orthopedics market; Prosthetics and Neuro Orthotics; Bracing and Supports; and Patient Care. Key revenue is generated from Prosthetics and Neuro Orthotics; segment.


Founded

1971

HQ

Denmark
Employees

4.2K+

Financials

LTM Revenue $6.1B

LTM EBITDA $1.2B

EV

$2.2B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Embla Medical Financials

Embla Medical has a last 12-month revenue of $6.1B and a last 12-month EBITDA of $1.2B.

In the most recent fiscal year, Embla Medical achieved revenue of $124M and an EBITDA of $24.7M.

Embla Medical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Embla Medical valuation multiples based on analyst estimates

Embla Medical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $114M $124M XXX XXX XXX
Gross Profit $64.0M $70.6M XXX XXX XXX
Gross Margin 56% 57% XXX XXX XXX
EBITDA $20.9M $24.7M XXX XXX XXX
EBITDA Margin 18% 20% XXX XXX XXX
Net Profit $6.2M $8.5M XXX XXX XXX
Net Margin 5% 7% XXX XXX XXX
Net Debt $38.3M $37.9M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Embla Medical Stock Performance

As of March 17, 2025, Embla Medical's stock price is DKK 29 (or $4).

Embla Medical has current market cap of DKK 12.4B (or $1.8B), and EV of DKK 15.3B (or $2.2B).

See Embla Medical trading valuation data

Embla Medical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$2.2B $1.8B XXX XXX XXX XXX $0.19

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Embla Medical Valuation Multiples

As of March 17, 2025, Embla Medical has market cap of $1.8B and EV of $2.2B.

Embla Medical's trades at 2.5x LTM EV/Revenue multiple, and 12.4x LTM EBITDA.

Analysts estimate Embla Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Embla Medical and 10K+ public comps

Embla Medical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $2.2B XXX XXX XXX
EV/Revenue 17.9x XXX XXX XXX
EV/EBITDA 89.9x XXX XXX XXX
P/E 181.9x XXX XXX XXX
P/E/Growth 0.8x XXX XXX XXX
EV/FCF 198.6x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Embla Medical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Embla Medical Valuation Multiples

Embla Medical's NTM/LTM revenue growth is 3%

Embla Medical's revenue per employee for the last fiscal year averaged $30K, while opex per employee averaged $15K for the same period.

Over next 12 months, Embla Medical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Embla Medical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Embla Medical and other 10K+ public comps

Embla Medical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 9% XXX XXX XXX XXX
EBITDA Margin 20% XXX XXX XXX XXX
EBITDA Growth 18% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 23% XXX XXX XXX XXX
Revenue per Employee $30K XXX XXX XXX XXX
Opex per Employee $15K XXX XXX XXX XXX
S&M Expenses to Revenue 36% XXX XXX XXX XXX
G&A Expenses to Revenue 8% XXX XXX XXX XXX
R&D Expenses to Revenue 5% XXX XXX XXX XXX
Opex to Revenue 49% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Embla Medical Public Comps

See public comps and valuation multiples for Medical Devices comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Philips XXX XXX XXX XXX XXX XXX
Perspective Therapeutics XXX XXX XXX XXX XXX XXX
SmartVest XXX XXX XXX XXX XXX XXX
InfuSystem XXX XXX XXX XXX XXX XXX
Myomo XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Embla Medical M&A and Investment Activity

Embla Medical acquired  XXX companies to date.

Last acquisition by Embla Medical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Embla Medical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Embla Medical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Embla Medical

When was Embla Medical founded? Embla Medical was founded in 1971.
Where is Embla Medical headquartered? Embla Medical is headquartered in Denmark.
How many employees does Embla Medical have? As of today, Embla Medical has 4.2K+ employees.
Who is the CEO of Embla Medical? Embla Medical's CEO is Mr. Sveinn Solvason.
Is Embla Medical publicy listed? Yes, Embla Medical is a public company listed on CSE.
What is the stock symbol of Embla Medical? Embla Medical trades under EMBLA ticker.
When did Embla Medical go public? Embla Medical went public in 2009.
Who are competitors of Embla Medical? Similar companies to Embla Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem.
What is the current market cap of Embla Medical? Embla Medical's current market cap is $1.8B
What is the current revenue of Embla Medical? Embla Medical's last 12-month revenue is $6.1B.
What is the current EBITDA of Embla Medical? Embla Medical's last 12-month EBITDA is $1.2B.
What is the current EV/Revenue multiple of Embla Medical? Current revenue multiple of Embla Medical is 2.5x.
What is the current EV/EBITDA multiple of Embla Medical? Current EBITDA multiple of Embla Medical is 12.4x.
What is the current revenue growth of Embla Medical? Embla Medical revenue growth between 2023 and 2024 was 9%.
Is Embla Medical profitable? Yes, Embla Medical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.